NEKTAR THERAPEUTICS — Director's Dealing 2019

Oct 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2019-10-15

Reporting Person: ROBIN HOWARD W (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-15	Common Stock	M	33333	$7.21	Acquired	346108	Direct
2019-10-15	Common Stock	S	8833	$16.35	Disposed	337275	Direct
2019-10-15	Common Stock	S	24500	$17.17	Disposed	312775	Direct
2019-10-16	Common Stock	M	33334	$7.21	Acquired	346109	Direct
2019-10-16	Common Stock	S	33334	$17.48	Disposed	312775	Direct
2019-10-17	Common Stock	M	33333	$7.21	Acquired	346108	Direct
2019-10-17	Common Stock	S	33333	$17.68	Disposed	312775	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-15	Stock Option	$7.21	M	33333	Disposed	2020-02-07	Common Stock (33333)	Direct
2019-10-16	Stock Option	$7.21	M	33334	Disposed	2020-02-07	Common Stock (33334)	Direct
2019-10-17	Stock Option	$7.21	M	33333	Disposed	2020-02-07	Common Stock (33333)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	410	Indirect

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin for certain options expiring on February 7, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $15.81 to $16.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F3: This transaction was executed in multiple trades at prices ranging from $16.88 to $17.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F4: This transaction was executed in multiple trades at prices ranging from $17.15 to $17.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F5: This transaction was executed in multiple trades at prices ranging from $17.44 to $17.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.